Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boston Scientific
BSX
|
+$240M |
| 2 |
eBay
EBAY
|
+$231M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$216M |
| 4 |
Ameren
AEE
|
+$196M |
| 5 |
Kohl's
KSS
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$552M |
| 2 |
Micron Technology
MU
|
+$425M |
| 3 |
Visa
V
|
+$225M |
| 4 |
Marathon Petroleum
MPC
|
+$225M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$218M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.6% |
| 2 | Healthcare | 12.02% |
| 3 | Technology | 11.62% |
| 4 | Industrials | 11.19% |
| 5 | Consumer Discretionary | 10.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARRY
2126
PUT
DELISTED
Array Biopharma Inc
ARRY
| $2.78M | ﹤0.01% |
+170,500
| New | +$2.73M |
|
2127
TriMas Corp
TRS
$1.43B
| $2.78M | ﹤0.01% |
105,924
+88,360
| +503% | +$2.29M |
|
2128
ANI Pharmaceuticals
ANIP
$1.8B
| $2.77M | ﹤0.01% |
47,544
+44,288
| +1,360% | +$2.81M |
|
2129
Protagonist Therapeutics
PTGX
$8.79B
| $2.75M | ﹤0.01% |
320,739
+128,009
| +66% | +$2.41M |
|
|
HDNG
2130
DELISTED
Hardinge Inc
HDNG
| $2.75M | ﹤0.01% |
+150,048
| New | +$2.74M |
|
2131
Amkor Technology
AMKR
$12.4B
| $2.75M | ﹤0.01% |
271,266
+118,051
| +77% | +$1.23M |
|
|
MDC
2132
DELISTED
M.D.C. Holdings, Inc.
MDC
| $2.75M | ﹤0.01% |
114,794
+21,332
| +23% | +$564K |
|
2133
Quanterix
QTRX
$164M
| $2.75M | ﹤0.01% |
161,132
-351,853
| -69% | -$7.05M |
|
2134
Beazer Homes USA
BZH
$877M
| $2.72M | ﹤0.01% |
170,788
-140,450
| -45% | -$2.49M |
|
2135
Old Dominion Freight Line
ODFL
$44.1B
| $2.72M | ﹤0.01% |
55,548
-476,703
| -90% | -$22.6M |
|
2136
Barnes & Noble Education
BNED
$431M
| $2.71M | ﹤0.01% |
3,933
-8,814
| -69% | -$6.21M |
|
2137
Cytosorbents Corp
CTSO
$22.7M
| $2.71M | ﹤0.01% |
384,330
+220,353
| +134% | +$1.67M |
|
|
AIMT
2138
DELISTED
Aimmune Therapeutics
AIMT
| $2.71M | ﹤0.01% |
+85,136
| New | +$3M |
|
2139
AMC Global Media
AMCX
$492M
| $2.71M | ﹤0.01% |
52,372
+16,719
| +47% | +$868K |
|
2140
Coty
COTY
$2.42B
| $2.7M | ﹤0.01% |
147,729
+48,080
| +48% | +$944K |
|
|
COL
2141
PUT
DELISTED
Rockwell Collins
COL
| $2.7M | ﹤0.01% |
20,000
+8,600
| +75% | +$1.17M |
|
2142
EPR Properties
EPR
$4.75B
| $2.69M | ﹤0.01% |
48,508
-838,861
| -95% | -$48.6M |
|
2143
PUT
Agilent Technologies
A
$39.1B
| $2.68M | ﹤0.01% |
+40,000
| New | +$2.8M |
|
2144
Jabil
JBL
$33B
| $2.67M | ﹤0.01% |
93,094
-247,704
| -73% | -$6.75M |
|
2145
Ceragon Networks
CRNT
$197M
| $2.67M | ﹤0.01% |
992,076
+963,058
| +3,319% | +$2.36M |
|
2146
EXL Service
EXLS
$5.14B
| $2.67M | ﹤0.01% |
239,185
-316,420
| -57% | -$3.78M |
|
|
AMPE
2147
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $2.66M | ﹤0.01% |
2,608
+1,990
| +322% | +$1.67M |
|
|
FIT
2148
CALL
DELISTED
Fitbit, Inc. Class A common stock
FIT
| $2.65M | ﹤0.01% |
+520,000
| New | +$2.77M |
|
2149
RenaissanceRe
RNR
$13.3B
| $2.65M | ﹤0.01% |
+19,142
| New | +$2.49M |
|
|
NAVG
2150
DELISTED
Navigators Group Inc
NAVG
| $2.64M | ﹤0.01% |
45,831
-90,038
| -66% | -$4.73M |
|
Similar funds
Millennium Management's Q1 2018 Portfolio in Review
As of Q1 2018, Millennium Management held 4,417 positions worth $74.9B, up 3.4% from $72.5B the previous quarter. Its ten largest holdings account for 6.3% of the portfolio.
Millennium Management deployed $3.3B of net new capital in Q1 2018, opening 664 new positions and adding to 1,467 existing holdings. Its largest new stake was Tiffany & Co.: 1,078,847 shares worth $105M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $552M trimmed.
- Millennium Management's largest Q1 2018 buy was Tiffany & Co.: 1,078,847 shares worth $105M.
- Millennium Management added most to Boston Scientific in Q1 2018, an estimated $240M increase.
- Millennium Management's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $552M.
- Millennium Management fully exited Equinix in Q1 2018, selling an estimated $152M.
- Millennium Management's ten largest holdings make up 6.3% of its $74.9B portfolio in Q1 2018.
- Millennium Management opened 664 new positions and closed 833 in Q1 2018.
- Millennium Management's portfolio value rose 3.4% quarter-over-quarter to $74.9B.
Based on Millennium Management's 13F filing for Q1 2018, filed 15 May 2018.